An Oklahoma judge has ordered Johnson & Johnson (J&J) to pay US$572m (£468m) for its role in the state’s opioid crisis.
After seven weeks, judge Thad Balkman determined the personal care giant and drug supplier ran a “false,
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.
Subscribe now Already a subscriber? Sign in here.
